Latest Insider Transactions at View Ray, Inc. (VRAY)
This section provides a real-time view of insider transactions for View Ray, Inc. (VRAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ViewRay, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ViewRay, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2021
|
Fosun International LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,000,000
-26.48%
|
$28,000,000
$7.02 P/Share
|
|
Oct 24
2021
|
Paul Ziegler Jr Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,891
-0.97%
|
$17,346
$6.81 P/Share
|
|
Oct 24
2021
|
Robert S Mc Cormack SVP Gen Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
31,121
-6.09%
|
$186,726
$6.81 P/Share
|
|
Oct 24
2021
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
74,032
-2.0%
|
$444,192
$6.81 P/Share
|
|
Aug 24
2021
|
Zachary William Stassen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+8.21%
|
$200,000
$5.32 P/Share
|
|
Jul 22
2021
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169,016
-4.37%
|
$1,014,096
$6.53 P/Share
|
|
Jul 01
2021
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,395
+36.38%
|
-
|
|
Jun 15
2021
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
168,580
-4.17%
|
$842,900
$5.83 P/Share
|
|
Jun 14
2021
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+12.89%
|
-
|
|
Jun 14
2021
|
Yili Kevin Xie Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+10.46%
|
-
|
|
Jun 14
2021
|
Phillip M Spencer Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+20.17%
|
-
|
|
Jun 14
2021
|
Daniel Jeffrey Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+11.19%
|
-
|
|
Jun 14
2021
|
Paul Ziegler Jr Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,137
+16.8%
|
-
|
|
Jun 14
2021
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,761
+1.25%
|
$41,522
$2.91 P/Share
|
|
Jun 14
2021
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+50.0%
|
-
|
|
Jun 14
2021
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+10.32%
|
-
|
|
Jun 14
2021
|
Brian K Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,759
+13.04%
|
-
|
|
Jun 08
2021
|
Strong Influence LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,300,000
-22.16%
|
$21,500,000
$5.97 P/Share
|
|
Jun 08
2021
|
Fosun International LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,300,000
-22.16%
|
$21,500,000
$5.97 P/Share
|
|
Jun 01
2021
|
Zachary William Stassen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50,530
-11.03%
|
$252,650
$5.98 P/Share
|
|
Mar 02
2021
|
Shahriar Matin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,621
-5.11%
|
$342,484
$4.51 P/Share
|
|
Mar 02
2021
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37,449
-0.92%
|
$149,796
$4.51 P/Share
|
|
Mar 02
2021
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,094
-5.18%
|
$152,376
$4.51 P/Share
|
|
Mar 01
2021
|
Phillip M Spencer Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,719
+26.6%
|
-
|
|
Mar 01
2021
|
Shahriar Matin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,174
-0.78%
|
$52,696
$4.66 P/Share
|
|
Mar 01
2021
|
Zachary William Stassen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,660
+19.74%
|
-
|
|
Mar 01
2021
|
Scott William Drake Director |
BUY
Grant, award, or other acquisition
|
Direct |
579,399
+12.45%
|
-
|
|
Mar 01
2021
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
26,347
-0.75%
|
$105,388
$4.66 P/Share
|
|
Mar 01
2021
|
James F. Dempsey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
104,613
+12.45%
|
-
|
|
Mar 01
2021
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,342
-1.0%
|
$25,368
$4.66 P/Share
|
|
Feb 09
2021
|
Phillip M Spencer Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,708
+41.46%
|
$38,832
$4.91 P/Share
|
|
Jan 04
2021
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
7,800
+7.18%
|
$46,800
$6.41 P/Share
|
|
Jan 04
2021
|
Daniel Jeffrey Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,820
+9.76%
|
$88,920
$6.41 P/Share
|
|
Jan 04
2021
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,580
+1.07%
|
$51,480
$6.41 P/Share
|
|
Jan 04
2021
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+6.41%
|
$46,800
$6.41 P/Share
|
|
Dec 31
2020
|
Daniel Jeffrey Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,184
+4.07%
|
$15,552
$3.82 P/Share
|
|
Dec 31
2020
|
Caley Castelein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,521
+0.32%
|
$7,563
$3.82 P/Share
|
|
Dec 31
2020
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,072
+2.82%
|
$9,216
$3.82 P/Share
|
|
Dec 31
2020
|
Yili Kevin Xie Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,456
+1.62%
|
$7,368
$3.82 P/Share
|
|
Nov 10
2020
|
Scott William Drake Director |
BUY
Open market or private purchase
|
Direct |
155,000
+4.06%
|
$465,000
$3.23 P/Share
|
|
Oct 24
2020
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
74,167
-2.07%
|
$222,501
$3.05 P/Share
|
|
Oct 24
2020
|
Shahriar Matin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91,626
-5.15%
|
$274,878
$3.05 P/Share
|
|
Oct 24
2020
|
James F. Dempsey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,012
-5.63%
|
$114,036
$3.05 P/Share
|
|
Jan 02
2020
|
Scott William Drake Director |
SELL
Payment of exercise price or tax liability
|
Direct |
139,289
-3.8%
|
$417,867
$3.82 P/Share
|
|
Dec 06
2019
|
Fosun International LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,348,242
+36.43%
|
$22,044,726
$3.13 P/Share
|
|
Aug 30
2018
|
Fosun International LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,702,702
+48.99%
|
$24,324,318
$9.25 P/Share
|
|
Aug 20
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
155,387
-2.06%
|
$1,398,483
$9.98 P/Share
|
|
Aug 16
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
366,220
-4.63%
|
$3,295,980
$9.94 P/Share
|
|
Aug 15
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,050
-0.98%
|
$702,450
$9.93 P/Share
|
|
Aug 14
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,975
-0.26%
|
$188,775
$9.94 P/Share
|